Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

01-05-2010 | Original article | Uitgave 5/2010

Netherlands Heart Journal 5/2010

Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy

Results of a prospective, two-centre registry

Tijdschrift:
Netherlands Heart Journal > Uitgave 5/2010
Auteurs:
A. Przybylski, P. Derejko, W. Kwaśniewski, D. Urbańczyk-Świć, J. Zakrzewska, W. Orszulak, M. Orczykowski, A. Filipecki, F. Walczak, M. Trusz-Gluza
Belangrijke opmerkingen
Cardiac Arrhythmias Department, Institute of Cardiology, Warsaw, Poland
Department of Cardiology, Medical University of Silesia, Katowice, Poland

Abstract

Introduction. The aim of the study was to define the prevalence of bleeding events in patients treated with dual antiplatelet therapy (DAT) in comparison with patients receiving only acetylsalicylic acid (ASA).
Methods. Prospective two-centre registry of all first implantations of pacemakers, cardioverter-defibrillators and cardiac resynchronisation therapy units in patients receiving ASA (n=194) or DAT (n=53).
Results. Bleeding complications were detected in 27 (16.2%) patients in the ASA group and in 13 (24.5%) in the DAT group. There was no significant difference in the overall number of complications between the patients receiving ASA or DAT, although there was a trend towards a higher incidence of overall complication rates in the DAT group (p=0.0637). The incidence of major complications (requiring blood transfusion or surgical intervention or prolonging hospital stay) was low (3.6%), and similar in both groups (3.6 and 3.8% respectively, ns). The rate of minor complications (subcutaneous haematomas) was greater in the DAT group (p=0.015).
Conclusions. Treatment with DAT does not increase the risk of major bleeding complications as a result of device implantation; however, minor complications are significantly more frequent. Our results suggest that DAT could be continued in patients undergoing device implantation with a moderate risk of bleeding complications. (Neth Heart J 2010;18:230-5.)

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

Netherlands Heart Journal

Het Netherlands Heart Journal wordt uitgegeven in samenwerking met de Nederlandse Vereniging voor Cardiologie en de Nederlandse Hartstichting. Het tijdschrift is Engelstalig en wordt gratis beschikbaa ...

Literatuur
Over dit artikel

Andere artikelen Uitgave 5/2010

Netherlands Heart Journal 5/2010 Naar de uitgave